Annovis Bio Shares Are Trading Higher After the Company Announced FDA Clearance to Begin Its Phase 3 Alzheimer's Studies and Align the Development Path for Buntanetap New Drug Applications (NDAs).
Annovis Bio Shares Are Trading Higher After the Company Announced FDA Clearance to Begin Its Phase 3 Alzheimer's Studies and Align the Development Path for Buntanetap New Drug Applications (NDAs).
annovis bio股价上涨，公司宣布获得FDA批准，开始进行第三阶段的阿尔茨海默病研究，并将调整开发巴他奈单抗新药申请(NDA)的路径。
Annovis Bio Shares Are Trading Higher After the Company Announced FDA Clearance to Begin Its Phase 3 Alzheimer's Studies and Align the Development Path for Buntanetap New Drug Applications (NDAs).
annovis bio股价上涨，公司宣布获得FDA批准，开始进行第三阶段的阿尔茨海默病研究，并将调整开发巴他奈单抗新药申请(NDA)的路径。
资讯热榜
更新时间